Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Lessons learned from using fMRI in the early clinical development of a mu-opioid receptor antagonist for disorders of compulsive consumption

    Functional magnetic resonance imaging (fMRI) has been widely used to gain a greater understanding of brain circuitry abnormalities in CNS disorders. fMRI has also been used to examine pharmacological modulatio...

    Pradeep J. Nathan, Geor Bakker in Psychopharmacology (2021)

  2. Article

    Open Access

    Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study

    The cholinergic system and M1 receptor remain an important target for symptomatic treatment of cognitive dysfunction. The selective M1 receptor partial agonist HTL0018318 is under development for the symptomatic ...

    Charlotte Bakker, Tim Tasker, Jan Liptrot, Ellen P. Hart in Alzheimer's Research & Therapy (2021)

  3. Article

    Erratum: Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype

    Correction to: Neuropsychopharmacology (2016) 41, 2647–2657; doi:10.1038/npp.2016.60; published online 18 May 2016 Page 9: The following should be added to the Acknowledgments section: ‘We gratefully acknowled...

    Hisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, Chris Dodds in Neuropsychopharmacology (2018)

  4. Article

    Open Access

    Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype

    The A118G single-nucleotide polymorphism (SNP rs1799971) in the μ-opioid receptor gene, OPRM1, has been much studied in relation to alcohol use disorders. The reported effects of allelic variation at this SNP on ...

    Hisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, Chris Dodds in Neuropsychopharmacology (2016)

  5. Article

    Open Access

    The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours

    The novel opioid receptor antagonist, GSK1421498, has been shown to attenuate reward-driven compulsive behaviours, such as stimulant drug seeking or binge eating, in animals and humans. Here, we report new dat...

    Eamonn Kelly, Stuart J. Mundell, Anna Sava, Adelheid L. Roth in Psychopharmacology (2015)

  6. Article

    Oxytocin Modulation of Amygdala Functional Connectivity to Fearful Faces in Generalized Social Anxiety Disorder

    The neuropeptide oxytocin (OXT) is thought to attenuate anxiety by dampening amygdala reactivity to threat in individuals with generalized social anxiety disorder (GSAD). Because the brain is organized into ne...

    Stephanie M Gorka, Daniel A Fitzgerald, Izelle Labuschagne in Neuropsychopharmacology (2015)

  7. Article

    Open Access

    Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and Alprazolam following insulin-induced hypoglycemia in humans

    The orexin-hypocretin system is important for translating peripheral metabolic signals and central neuronal inputs to a diverse range of behaviors, from feeding, motivation and arousal, to sleep and wakefulnes...

    Ameera X. Patel, Sam R. Miller, Pradeep J. Nathan, Ponmani Kanakaraj in Psychopharmacology (2014)

  8. Article

    Modulation of Resting-State Amygdala-Frontal Functional Connectivity by Oxytocin in Generalized Social Anxiety Disorder

    Generalized social anxiety disorder (GSAD) is characterized by aberrant patterns of amygdala-frontal connectivity to social signals of threat and at rest. The neuropeptide oxytocin (OXT) modulates anxiety, str...

    Sonam Dodhia, Avinash Hosanagar, Daniel A Fitzgerald in Neuropsychopharmacology (2014)

  9. No Access

    Article

    Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects

    Black box warnings for young adults under the age of 25 years indicate that antidepressants may increase risk of suicide. While underlying mechanisms for age-related treatment effects remain unclear, vagally m...

    Andrew H. Kemp, Tim Outhred, Sasha Saunders, Andre R. Brunoni in Psychopharmacology (2014)

  10. No Access

    Article

    BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

  11. Scientific advancement in neuroscience has not been effectively translated into therapies for neurological diseases. In general, 'toxin reducing' approaches (f...

  12. Bai Lu, Guhan Nagappan, **aoming Guan, Pradeep J. Nathan in Nature Reviews Neuroscience (2013)

  13. No Access

    Article

    Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals

    Translational research implicates the mu opioid neurochemical system in hedonic processing, but its role in dissociable high-level cognitive functions is not well understood. Binge-eating represents a useful m...

    Samuel R. Chamberlain, Karin Mogg, Brendan P. Bradley, Annelize Koch in Psychopharmacology (2012)

  14. Article

    Open Access

    Inhibition of Opioid Transmission at the μ-Opioid Receptor Prevents Both Food Seeking and Binge-Like Eating

    Endogenous opioids, and in particular μ-opioid receptors, have been linked to hedonic and rewarding mechanisms engaged during palatable food intake. The aim of this study was to investigate the effects of GSK1...

    Chiara Giuliano, Trevor W Robbins, Pradeep J Nathan in Neuropsychopharmacology (2012)

  15. No Access

    Article

    Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants

    The loudness dependence of the auditory evoked potential (LDAEP) has been reported to be an effective non-invasive measure of central serotonergic neurotransmission. However, acute manipulations of the seroton...

    Julian G. Simmons, Pradeep J. Nathan, Gregor Berger in Psychopharmacology (2011)

  16. Article

    Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder

    Patients with generalized social anxiety disorder (GSAD) exhibit heightened activation of the amygdala in response to social cues conveying threat (eg, fearful/angry faces). The neuropeptide oxytocin (OXT) dec...

    Izelle Labuschagne, K Luan Phan, Amanda Wood, Mike Angstadt in Neuropsychopharmacology (2010)

  17. No Access

    Article

    Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants

    Schizophrenia is commonly associated with impairments in pre-attentive change detection, as represented by reduced mismatch negativity (MMN). While the neurochemical basis of MMN has been linked to N-methyl-d-asp...

    Sumie Leung, Rodney J. Croft, Valérie Guille, Kirsty Scholes in Psychopharmacology (2010)

  18. No Access

    Article

    Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study

    Serotonergic (SSRI) and noradrenergic (NRI) antidepressants modulate biases in emotional processing such that perceptual bias is shifted away from negative and towards positive emotional material. However, the...

    Rebecca Kerestes, Izelle Labuschagne, Rodney J. Croft in Psychopharmacology (2009)

  19. Article

    Differential Effects of Acute Serotonin and Dopamine Depletion on Prepulse Inhibition and P50 Suppression Measures of Sensorimotor and Sensory Gating in Humans

    Schizophrenia is associated with impairments of sensorimotor and sensory gating as measured by prepulse inhibition (PPI) of the acoustic startle response and P50 suppression of the auditory event-related poten...

    Collette Mann, Rodney J Croft, Kirsty E Scholes, Alan Dunne in Neuropsychopharmacology (2008)

  20. No Access

    Article

    Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls

    Schizophrenia is commonly associated with impairments in pre-attentive change detection as represented by reduced mismatch negativity (MMN). The neurochemical basis of MMN has been linked to N-methyl-d-aspartate ...

    Sumie Leung, Rodney J. Croft, Barry V. O’Neill, Pradeep J. Nathan in Psychopharmacology (2008)

  21. No Access

    Article

    High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans

    The loudness dependence of the auditory evoked Potential (LDAEP) has been suggested to be a putative marker of central serotonin function, with reported abnormalities in clinical disorders presumed to reflect ...

    Barry V. O’Neill, Rodney J. Croft, Sumie Leung, Chris Oliver in Psychopharmacology (2007)

  22. No Access

    Article

    Acute dopamine D1 and D2 receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects

    Schizophrenia is commonly associated with an impairment in pre-attentive change detection, as represented by reduced mismatch negativity (MMN), an auditory event related potential. While the neurochemical basi...

    Sumie Leung, Rodney J. Croft, Torsten Baldeweg, Pradeep J. Nathan in Psychopharmacology (2007)

previous disabled Page of 2